TSE:7261
TSE:7261Auto

Perrone Robotics’ Patent Suits Over Automated Driving Software Might Change The Case For Investing In Mazda Motor (TSE:7261)

Perrone Robotics and its affiliate recently filed patent infringement lawsuits in U.S. federal courts against seven major automakers, including Mazda, alleging unauthorized use of their automated vehicle and robotics technologies in advanced driving systems. The case spotlights how foundational software platforms for autonomy, once pioneered by a smaller specialist like Perrone, have become deeply embedded in mainstream vehicle safety and convenience features across the industry. We’ll now...
TSE:5301
TSE:5301Chemicals

Tokai Carbon (TSE:5301) Valuation Check After U.S. Subsidiary Reorganization and Governance Overhaul

Tokai Carbon (TSE:5301) is shaking up its U.S. footprint by folding three fine carbon subsidiaries into a single entity under its American holding company, a structural tidy up that could quietly improve efficiency and oversight. See our latest analysis for Tokai Carbon. Despite the recent U.S. restructuring push, market sentiment has been mixed. The latest pullback leaves the 1 year total shareholder return at 14.23%, while shorter term share price momentum has softened. This hints at fading...
TSE:1860
TSE:1860Construction

Toda (TSE:1860) Valuation Check After Strong 12‑Month Share Price Rally

Toda (TSE:1860) has quietly outperformed the broader Japanese construction sector over the past year, with shares up roughly 33% over 12 months and about 26% year to date, inviting a closer look. See our latest analysis for Toda. That upward move has come in bursts rather than a straight line, with a strong 30 day share price return and an impressive multi year total shareholder return. Together, these suggest momentum is still building as investors re rate Toda's prospects. If Toda's run has...
TSE:4506
TSE:4506Pharmaceuticals

Taking a Fresh Look at Sumitomo Pharma (TSE:4506)’s Valuation After Its Strong 1-Year Share Price Surge

Sumitomo Pharma (TSE:4506) has quietly turned into a momentum story, with the share price climbing roughly 36% over the past 3 months and tripling over the past year, far outpacing its earnings growth. See our latest analysis for Sumitomo Pharma. That surge sits against a powerful backdrop, with a 90 day share price return of 36.14% and a 1 year total shareholder return of 326.00%. This signals strong, still building momentum as investors reassess Sumitomo Pharma’s risk reward profile. Given...
TSE:6954
TSE:6954Machinery

Why Fanuc (TSE:6954) Is Up 18.0% After Announcing Nvidia-Powered “Physical AI” Robot Partnership

Earlier this week, robot maker Fanuc announced a partnership with U.S. chip company Nvidia to develop industrial robots powered by “physical AI,” lifting sentiment across Japan’s robotics names and helping the Nikkei 225 close at a multi-week high. The collaboration highlights how advances in AI hardware and software are increasingly converging on factory floors, potentially reshaping how investors think about automation leaders like Fanuc. Next, we will examine how Fanuc’s Nvidia-powered...